Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) 2018-04-27 20:38
Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) 2018-04-27 18:48
NeuroVive Presents NVP025 Mitochondrial Myopathy Project Progress at Mitochondrial Medicine Conference 2018-04-20 18:52
NeuroVive's Board Members, Senior Executives and Employees Will Subscribe Units in the Ongoing Rights Issue 2018-04-20 15:21
NeuroVive's KL1333 Receives FDA Orphan Drug Designation for Treatment of Mitochondrial Diseases 2018-04-18 15:57
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment 2018-04-17 15:03
NeuroVive Pharmaceutical AB Year End Report January - December 2017 2018-02-20 16:05
Notice of Extraordinary General Meeting of NeuroVive Pharmaceutical AB (publ) 2018-02-15 16:35
NeuroVive Decides on a Rights Issue for Continued Drug Development 2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project 2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference 2018-01-03 16:10
NeuroVive's KL1333 Program Granted Orphan Drug Designation by the European Commission 2017-12-13 16:11
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 2017-12-11 18:56
Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) 2017-11-30 19:51
NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone 2017-11-30 16:26
NeuroVive Pharmaceutical AB Interim Report January - September 2017 2017-11-21 15:56
NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference 2017-11-15 16:48
NeuroVive Board Chair Resigns, New Chair Elected 2017-11-07 15:55
NeuroVive Conducts a Directed New Share Issue of SEK 5.3 Million 2017-11-03 16:33
NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development 2017-10-31 16:32
1 2 3 4